A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models
2021
Nature Communications
AbstractMost anti-influenza drugs currently used, such as oseltamivir and zanamivir, inhibit the enzymatic activity of neuraminidase. However, neuraminidase inhibitor-resistant viruses have already been identified from various influenza virus isolates. Here, we report the development of a class of macrocyclic peptides that bind the influenza viral envelope protein hemagglutinin, named iHA. Of 28 iHAs examined, iHA-24 and iHA-100 have inhibitory effects on the in vitro replication of a wide
doi:10.1038/s41467-021-22964-w
pmid:33976181
fatcat:zcygmltrsvhdlbmdhfzt7gb76i